Robert Naclerio to Antibodies, Anti-Idiotypic
This is a "connection" page, showing publications Robert Naclerio has written about Antibodies, Anti-Idiotypic.
Connection Strength
0.673
-
Should clinicians use omalizumab for the treatment of nasal polyps? J Allergy Clin Immunol. 2013 Jul; 132(1):247.
Score: 0.428
-
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
Score: 0.089
-
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy. 2006 Sep; 61(9):1086-96.
Score: 0.067
-
Monoclonal Antibodies for the Treatment of Nasal Polyps. Immunol Allergy Clin North Am. 2017 05; 37(2):357-367.
Score: 0.035
-
Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
Score: 0.028
-
Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991 Apr; 87(4):855-66.
Score: 0.023
-
The pharmacologic control of mediator release from human basophils and mast cells. Respiration. 1986; 50 Suppl 2:116-22.
Score: 0.004